World Pharma News - New forecasting technique 'set to move pharma to new areas'

World Pharma News is one of the world's leading web-based pharmaceutical news publications. Our subscribers are continuously informed about the latest and most prominent worldwide pharmaceutical news.

Home

News Channels

Conferences & Events

New forecasting technique 'set to move pharma to new areas'

World Pharma News RSS Channel

Subscribe to World Pharma News by Email

Research & Development

More in: Research & Development

Conferences & Events

More in: Conferences & Events

New forecasting technique 'set to move pharma to new areas'

Wednesday, 29 August 2007

It's set to turn business intelligence on its head. One senior pharma director of strategic planning has announced it 'will move pharma to new areas'. It's a new forecasting technology that's already been adopted by Novartis, GSK, Lilly, J&J and Pfizer. It's called 'A Prediction Market'.

There are three places you can find out more about Prediction Markets and pharma:

Free Exclusive Eyeforpharma Podcast which includes the highlights of a recent exclusive conference speech and an interview with the world academic expert all in just 10-minutes!
A Free White Paper on the subject, which includes a concise explanation, statistics and quotes
A highly informative live 1-hour online conference on Wednesday 5th September for only $99 if you book this week (reduced from $199). Learn from the experts - you'll hear 3 world class authorities addressing the subject.

More information and all 3 sources can be accessed at www.eyeforpharma.com/virtual/forecastingpm/

About EyeforPharma
EyeforPharma is a global pharmaceutical business strategy information provider with a highly reputable and worldwide presence in the pharma industry. It is renowned for producing top level conferences that attract the highest level of speakers to deliver presentations on cutting edge pharmaceutical business strategies. It provides business intelligence and analysis online at www.eyeforpharma.com. EyeforPharma also has a very strong foothold in the European, US and Japanese markets.

Bookmark with: